Funded Projects › FP7
TRANCYST · Translational research (training) in Polycystic Kidney Disease
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is an inherited kidney disorder with a prevalence of more than 1:1000, characterized by the development of renal cysts, slowly progressing towards end-stage renal disease. ADPKD is often associated with extra-renal complications, which can be devastating. Current therapy is directed towards limiting the morbidity and mortality from these complications, whereas effective specific treatments targeting the renal cystic disease are missing.Translational research using innovative approaches from molecular genetics, basic sciences to clinical applications are necessary to unravel the disease mechanism and to develop interventions, monitoring of cystic renal disease progression and to slow down renal cystic disease.In this context, the aim of TranCYST is to offer a multidisciplinary research training program to young researchers for the identification, characterization, and development of novel treatments in ADPKD, to prepare them to become leading scientists who are able to translate fundamental research questions to the clinic and vice versa,
Consortium · 7 organisations
ACADEMISCH ZIEKENHUIS LEIDEN
NL · €757,933
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
FR · €258,149
THE UNIVERSITY OF SHEFFIELD
UK · €575,613
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI
IT · €243,038
University of Zurich
CH · €497,674
GENOMIC INVESTMENTS BV
NL · €207,057
MOSAIQUES DIAGNOSTICS GMBH
DE · €224,269
Research fields
← Find collaborators and more funded projects
Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.